FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> FDA   Phase II   Genentech   Avastin
Syndicate content

breast cancer News

Most Popular breast cancer Story

FDA rewards Roche with priority review for blockbuster cancer drug

After racking up a solid set of late-stage data on the experimental breast cancer drug pertuzumab late last year, Roche ($RHHBY) and Genentech scored priority review status for the program, shaving Read more...

Latest Headlines